doi: 10.1126/science.191908.
Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents
- PMID: 191908
- DOI: 10.1126/science.191908
Item in Clipboard
Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents
Science.
.
Abstract
A hypothetical model of the active site of angiotensin-converting enzyme, based on known chemical and kinetic properties of the enzyme, has enabled us to design a new class of potent and specific inhibitors. These compounds, carboxyalkanoyl and mercaptoalkanoyl derivatives of proline, inhibit the contractile response of guinea pig ileal strip to angiotensin I and augment its response to bradykinin. When administered orally to rats, these agents inhibit the pressor effect of angiotensin I, augment the vasodepressor effect of bradykinin, and lower blood pressure in a model of renovascular hypertension.
Similar articles
-
Captopril (SQ 14,225) (D-3-mercapto-2-methylpropranoyl-L-proline): a novel orally active inhibitor of angiotensin-converting enzyme and antihypertensive agent.Prog Cardiovasc Dis. 1978 Nov-Dec;21(3):183-94. doi: 10.1016/0033-0620(78)90024-5. Prog Cardiovasc Dis. 1978. PMID: 214818 Review. No abstract available.
-
Development and design of specific inhibitors of angiotensin-converting enzyme.Am J Cardiol. 1982 Apr 21;49(6):1390-4. doi: 10.1016/0002-9149(82)90348-4. Am J Cardiol. 1982. PMID: 6176105
-
[Use of specific angiotensin inhibitors in the diagnosis and treatment of arterial hypertension].Ter Arkh. 1979;51(5):99-108. Ter Arkh. 1979. PMID: 222004 Review. Russian. No abstract available.
-
SQ 14,225 (D-3-mercapto-2-methylpropanoyl-l-proline), a novel orally active inhibitor of angiotensin I-converting enzyme.J Pharmacol Exp Ther. 1978 Feb;204(2):271-80. J Pharmacol Exp Ther. 1978. PMID: 202692 No abstract available.
-
Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril.Arch Int Pharmacodyn Ther. 1988 Mar-Apr;292:203-22. Arch Int Pharmacodyn Ther. 1988. PMID: 3293542
Cited by
-
Bioactive peptides from muscle sources: meat and fish.Nutrients. 2011 Sep;3(9):765-91. doi: 10.3390/nu3090765. Epub 2011 Aug 31. Nutrients. 2011. PMID: 22254123 Free PMC article. Review.
-
Chemical design of cilazapril.Br J Clin Pharmacol. 1989;27 Suppl 2(Suppl 2):133S-137S. doi: 10.1111/j.1365-2125.1989.tb03474.x. Br J Clin Pharmacol. 1989. PMID: 2548550 Free PMC article.
-
Intestine-Specific, Oral Delivery of Captopril/Montmorillonite: Formulation and Release Kinetics.Nanoscale Res Lett. 2011 Dec;6(1):15. doi: 10.1007/s11671-010-9749-0. Epub 2010 Aug 27. Nanoscale Res Lett. 2011. PMID: 27502639 Free PMC article.
-
Roles of proteolysis in regulation of GPCR function.Br J Pharmacol. 2013 Feb;168(3):576-90. doi: 10.1111/j.1476-5381.2012.02234.x. Br J Pharmacol. 2013. PMID: 23043558 Free PMC article. Review.
-
Depressor effects and pharmacokinetics of single and consecutive doses of delapril in hypertensive patients with normal or impaired renal function.Cardiovasc Drugs Ther. 1990 Oct;4(5):1417-23. doi: 10.1007/BF02018270. Cardiovasc Drugs Ther. 1990. PMID: 2177631
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
